Cargando…

How to measure (or not) compliance to eradication therapy

This study aimed to test a novel method of compliance measurement in Portuguese community pharmacy in Helicobacter pylori patients. A case series design was used where compliance indicators were electronically measured, aside with patients’ reports. Experienced adverse drug reactions, perceived bene...

Descripción completa

Detalles Bibliográficos
Autores principales: Martins, Ana Paula, Ferreira, Ana Patrícia, da Costa, Filipa Alves, Cabrita, José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centro de Investigaciones y Publicaciones Farmaceuticas 2006
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166150/
https://www.ncbi.nlm.nih.gov/pubmed/25247005
_version_ 1782335217231462400
author Martins, Ana Paula
Ferreira, Ana Patrícia
da Costa, Filipa Alves
Cabrita, José
author_facet Martins, Ana Paula
Ferreira, Ana Patrícia
da Costa, Filipa Alves
Cabrita, José
author_sort Martins, Ana Paula
collection PubMed
description This study aimed to test a novel method of compliance measurement in Portuguese community pharmacy in Helicobacter pylori patients. A case series design was used where compliance indicators were electronically measured, aside with patients’ reports. Experienced adverse drug reactions, perceived benefit of therapy and quality of life were also measured. Mean compliance proportion was 56% and a positive impact on patients’ perceived health status was found. The method used was welcomed by community pharmacists, albeit having an influence on patients’ normal behaviour.
format Online
Article
Text
id pubmed-4166150
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher Centro de Investigaciones y Publicaciones Farmaceuticas
record_format MEDLINE/PubMed
spelling pubmed-41661502014-09-22 How to measure (or not) compliance to eradication therapy Martins, Ana Paula Ferreira, Ana Patrícia da Costa, Filipa Alves Cabrita, José Pharm Pract (Granada) Original Research This study aimed to test a novel method of compliance measurement in Portuguese community pharmacy in Helicobacter pylori patients. A case series design was used where compliance indicators were electronically measured, aside with patients’ reports. Experienced adverse drug reactions, perceived benefit of therapy and quality of life were also measured. Mean compliance proportion was 56% and a positive impact on patients’ perceived health status was found. The method used was welcomed by community pharmacists, albeit having an influence on patients’ normal behaviour. Centro de Investigaciones y Publicaciones Farmaceuticas 2006 2006-07-31 /pmc/articles/PMC4166150/ /pubmed/25247005 Text en Copyright: © Pharmacy Practice http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY-NC-ND 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Research
Martins, Ana Paula
Ferreira, Ana Patrícia
da Costa, Filipa Alves
Cabrita, José
How to measure (or not) compliance to eradication therapy
title How to measure (or not) compliance to eradication therapy
title_full How to measure (or not) compliance to eradication therapy
title_fullStr How to measure (or not) compliance to eradication therapy
title_full_unstemmed How to measure (or not) compliance to eradication therapy
title_short How to measure (or not) compliance to eradication therapy
title_sort how to measure (or not) compliance to eradication therapy
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4166150/
https://www.ncbi.nlm.nih.gov/pubmed/25247005
work_keys_str_mv AT martinsanapaula howtomeasureornotcompliancetoeradicationtherapy
AT ferreiraanapatricia howtomeasureornotcompliancetoeradicationtherapy
AT dacostafilipaalves howtomeasureornotcompliancetoeradicationtherapy
AT cabritajose howtomeasureornotcompliancetoeradicationtherapy